BioLife Solutions, Inc.
US ˙ NasdaqCM ˙ US09062W2044

SecurityBLFS / BioLife Solutions, Inc.
InsiderSarah Aebersold
This page shows the track record and history of Aebersold Sarah insider trades in BioLife Solutions, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Sarah Aebersold in BLFS / BioLife Solutions, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

BLFS / BioLife Solutions, Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Sarah Aebersold in BLFS / BioLife Solutions, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2023-04-06 739 20.0300 739 20.0300 14,802 207 8.9900 -8,158 -55.12
2023-03-01 1,022 22.7500 1,022 22.7500 23,250
2023-02-09 55 24.6000 55 24.6000 1,353
2023-01-19 374 22.9300 374 22.9300 8,576
2022-11-10 38 23.1600 38 23.1600 880
2022-10-28 272 21.7600 272 21.7600 5,919
2022-08-10 40 23.1700 40 23.1700 927
2022-07-22 252 17.8500 252 17.8500 4,498
2022-05-13 40 12.3200 40 12.3200 493
2022-04-21 325 13.9400 325 13.9400 4,530
2022-02-10 197 29.3800 197 29.3800 5,788
2022-01-20 332 30.2400 332 30.2400 10,040
2021-10-20 272 42.3400 272 42.3400 11,516
2021-07-20 1,059 45.1000 1,059 45.1000 47,761

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

BLFS / BioLife Solutions, Inc. Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2025-09-17 2025-09-15 4 Aebersold Sarah BLFS Common Stock S - Sale D 25.6100 -714 -18 77,357
2025-09-15 2025-09-11 4 Aebersold Sarah BLFS Common Stock S - Sale D 26.8300 -233 -6 78,071
2025-08-28 2025-08-26 4 Aebersold Sarah BLFS Common Stock S - Sale D 25.4400 -219 -6 78,304
2025-07-09 2025-07-07 4 Aebersold Sarah BLFS Common Stock S - Sale D 22.2700 -198 -4 78,523
2025-06-18 2025-06-16 4 Aebersold Sarah BLFS Common Stock S - Sale D 22.2300 -711 -16 78,721
2025-06-12 2025-06-10 4 Aebersold Sarah BLFS Common Stock S - Sale D 23.7000 -235 -6 79,432
2025-05-30 2025-05-28 4 Aebersold Sarah BLFS Common Stock S - Sale D 22.4600 -217 -5 79,667
2025-04-11 2025-04-09 4 Aebersold Sarah BLFS Common Stock S - Sale D 20.1100 -210 -4 79,884
2025-04-03 2025-04-01 4 Aebersold Sarah BLFS Common Stock S - Sale D 22.6600 -5,771 -131 80,094
2025-03-20 2025-03-17 4/A Aebersold Sarah BLFS Common Stock S - Sale D 25.4400 -2,695 -69 48,797
2025-03-20 2025-03-18 4 Aebersold Sarah BLFS Common Stock A - Award D 21,789 85,865
2025-03-20 2025-03-18 4 Aebersold Sarah BLFS Common Stock A - Award D 15,279 64,076
2025-03-18 2025-03-17 4 Aebersold Sarah BLFS Common Stock S - Sale D 25.4400 -2,695 -69 43,165
2025-03-18 2025-03-14 4 Aebersold Sarah BLFS Common Stock S - Sale D 24.9600 -5,632 -141 45,860
2025-03-13 2025-03-12 4 Aebersold Sarah BLFS Common Stock S - Sale D 26.3400 -7,324 -193 51,492
2025-03-13 2025-03-11 4 Aebersold Sarah BLFS Common Stock S - Sale D 25.0000 -1,091 -27 58,816
2025-03-05 2025-03-03 4 Aebersold Sarah BLFS Common Stock S - Sale D 25.4600 -284 -7 59,907
2025-02-14 2025-02-12 4 Aebersold Sarah BLFS Common Stock S - Sale D 26.5400 -53 -1 60,191
2025-01-08 2025-01-06 4 Aebersold Sarah BLFS Common Stock S - Sale D 27.0200 -240 -6 60,244
2024-11-29 2024-11-26 4 Aebersold Sarah BLFS Common Stock S - Sale D 27.2000 -216 -6 60,484
2024-11-01 2024-10-30 4 Aebersold Sarah BLFS Common Stock S - Sale D 23.1500 -203 -5 60,700
2024-09-18 2024-09-16 4 Aebersold Sarah BLFS Common Stock S - Sale D 25.1200 -229 -6 60,903
2024-09-18 2024-08-21 4 Aebersold Sarah BLFS Common Stock S - Sale D 25.6100 -64 -2 61,132
2024-09-18 2024-07-19 4 Aebersold Sarah BLFS Common Stock S - Sale D 21.0100 -300 -6 61,196
2024-09-18 2024-07-11 4 Aebersold Sarah BLFS Common Stock S - Sale D 20.5400 -187 -4 61,496
2024-07-03 2024-07-01 4 Aebersold Sarah BLFS Common Stock S - Sale D 21.0300 -3,000 -63 61,683
2024-05-31 2024-05-29 4 Aebersold Sarah BLFS Common Stock S - Sale D 21.7800 -345 -8 64,683
2024-05-21 2024-05-17 4 Aebersold Sarah BLFS Common Stock S - Sale D 22.1800 -57 -1 65,028
2024-04-23 2024-04-22 4 Aebersold Sarah BLFS Common Stock S - Sale D 16.5000 -410 -7 65,085
2024-04-23 2024-04-18 4 Aebersold Sarah BLFS Common Stock S - Sale D 15.3100 -348 -5 65,495
2024-04-03 2024-04-01 4 Aebersold Sarah BLFS Common Stock S - Sale D 17.6500 -4,000 -71 65,843
2024-03-12 2024-03-12 4 Aebersold Sarah BLFS Common Stock S - Sale D 16.6000 -4,361 -72 69,843
2024-03-12 2024-03-11 4 Aebersold Sarah BLFS Common Stock S - Sale D 17.4200 -269 -5 74,204
2024-03-12 2024-03-08 4 Aebersold Sarah BLFS Common Stock A - Award D 17,523 74,473
2024-03-12 2024-03-08 4 Aebersold Sarah BLFS Common Stock A - Award D 15,144 56,950
2024-02-23 2024-02-21 4 Aebersold Sarah BLFS Common Stock S - Sale D 17.3500 -58 -1 41,806
2024-01-25 2024-01-23 4 Aebersold Sarah BLFS Common Stock S - Sale D 17.1100 -336 -6 41,864
2024-01-23 2024-01-19 4 Aebersold Sarah BLFS Common Stock S - Sale D 16.7600 -862 -14 42,200
2023-12-04 2023-12-01 4 Aebersold Sarah BLFS Common Stock S - Sale D 12.3700 -394 -5 43,062
2023-11-15 2023-11-13 4 Aebersold Sarah BLFS Common Stock S - Sale D 10.7700 -76 -1 43,456
2023-08-29 2023-08-25 4 Aebersold Sarah BLFS Common Stock S - Sale D 10.9900 -347 -4 43,532
2023-08-16 2023-08-14 4 Aebersold Sarah BLFS Common Stock S - Sale D 12.3800 -104 -1 43,879
2023-07-26 2023-07-24 4 Aebersold Sarah BLFS Common Stock S - Sale D 19.5000 -462 -9 43,983
2023-06-02 2023-05-31 4 Aebersold Sarah BLFS Common Stock S - Sale D 23.2100 -337 -8 44,445
2023-05-17 2023-05-15 4 Aebersold Sarah BLFS Common Stock S - Sale D 18.7100 -72 -1 44,782
2023-05-16 2023-04-06 4/A Aebersold Sarah BLFS Common Stock S - Sale D 20.0300 -739 -15 45,146
2023-05-16 2023-03-31 4/A Aebersold Sarah BLFS Common Stock M - Exercise D 2,795 45,885
2023-04-21 2023-04-19 4 Aebersold Sarah BLFS Common Stock S - Sale D 19.3300 -292 -6 42,059
2023-04-10 2023-04-06 4 Aebersold Sarah BLFS Common Stock S - Sale D 20.0300 -739 -15 42,351
2023-03-03 2023-03-01 4 Aebersold Sarah BLFS Common Stock S - Sale D 22.7500 -1,022 -23 43,090
2023-02-13 2023-02-09 4 Aebersold Sarah BLFS Common Stock S - Sale D 24.6000 -55 -1 44,112
2023-01-20 2023-01-19 4 Aebersold Sarah BLFS Common Stock S - Sale D 22.9300 -374 -9 44,167
2023-01-10 2023-01-03 4 Aebersold Sarah BLFS Common Stock A - Award D 12,450 44,541
2022-11-14 2022-11-10 4 Aebersold Sarah BLFS Common Stock S - Sale D 23.1600 -38 -1 32,091
2022-10-31 2022-10-28 4 Aebersold Sarah BLFS Common Stock S - Sale D 21.7600 -272 -6 32,129
2022-08-11 2022-08-10 4 Aebersold Sarah BLFS Common Stock S - Sale D 23.1700 -40 -1 32,401
2022-07-26 2022-07-22 4 Aebersold Sarah BLFS Comon Stock S - Sale D 17.8500 -252 -4 32,441
2022-05-17 2022-05-13 4 Aebersold Sarah BLFS Common Stock S - Sale D 12.3200 -40 -0 32,693
2022-04-22 2022-04-21 4 Aebersold Sarah BLFS Common Stock S - Sale D 13.9400 -325 -5 32,733
2022-03-09 2022-02-24 4 Aebersold Sarah BLFS Restricted Stock Award A - Award D 0.00 14,019 14,019
2022-03-09 2022-02-24 4 Aebersold Sarah BLFS Common Stock A - Award D 14,019 33,058
2022-02-14 2022-02-10 4 Aebersold Sarah BLFS Common Stock S - Sale D 29.3800 -197 -6 19,039
2022-01-24 2022-01-20 4 Aebersold Sarah BLFS Common Stock S - Sale D 30.2400 -332 -10 19,236
2021-10-22 2021-10-20 4 Aebersold Sarah BLFS Common Stock S - Sale D 42.3400 -272 -12 19,568
2021-07-22 2021-07-20 4 Aebersold Sarah BLFS Common Stock S - Sale D 45.1000 -1,059 -48 19,840
2021-02-19 2021-02-08 4 Aebersold Sarah BLFS Restricted Stock Award A - Award D 0.00 2,795 2,795
2021-02-19 2021-02-08 4 Aebersold Sarah BLFS Common Stock A - Award D 2,795 20,899
2021-01-07 3 Aebersold Sarah BLFS Common Stock D 18,104
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)